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Denture stomatitis is a common inflammatory reaction affecting denture wearers, 
multifactorial etiology, which is usually associated with Candida species, particularly 
Candida albicans. The treatment of Candida-associated denture stomatitis (CADS) is 
difficult and complex due to its multifactorial etiology, common recurrences, as well as 
the lack of antifungal drug efficacy. This review aims to critically discuss several key 
factors affecting adhesion and biofilm formation of Candida species on acrylic surface, 
as well as the use of herbs, proposed as an alternative in the treatment of CADS. Many 
factors affect adhesion and biofilm formation of Candida spp.  on acrylic surfaces, such 
as surface roughness of the inner surface of the prosthesis, salivary pellicle, 
hydrophobic and electrostatic interactions. Having in mind that denture stomatitis is a 
common disease in total denture wearer, that it is most common in fungal etiology and 
that biofilm development increases yeast resistance, application of non-synthetic, 
completely natural substances, such as essential oils and extracts, may be suggested 
as a promising alternative for treatment of CADS.  Acta Medica Medianae 2014; 
53(1):73-79. 
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Introduction 
 
  Denture stomatitis is a common inflam-
matory reaction affecting denture wearers (1,2). 
It is manifested as inflammation and erythema of 
the oral mucosal areas underlying dentures, 
more frequent in the maxillary mucosa than in 
the mandibular mucosa (Figure 1) (1-4). Although 
etiology of denture stomatitis is multifactorial, it 
is usually associated with Candida  species, 
particularly Candida albicans (C. albicans) (1,2). 
The treatment of Candida-associated denture 
stomatitis (CADS) is difficult and complex due to 
its multifactorial etiology, common recurrences, 
as well as lack of antifungal drug efficacy (2-5). 
The therapeutic strategy includes the use of 
topical and systemic antifungal drugs, chemical 
substances such as chlorhexidine and sodium 
hypochlorite, proper denture hygiene and the 
removal of dentures at night (3-5). The most 
commonly used antifungal drugs are ampho-
tericin B, nystatin, miconazole and fluconazole. 
Considering the fact that the chemically used 
antimycotic drugs have side effect regarding 
toxicity, development of fungal resistance, lack of 
fungicidal efficacy, drug-drug interactions, high 
cost, alternative in using plants and their essential 
oils is a new trend in treatment of CADS (3,5-9).  
 
 
 
Figure 1. Localized plane inflammation 
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This review aims to critically discuss several 
key factors which affect adhesion and biofilm 
formation of Candida species on acrylic surface, 
as well as the use of herbs, proposed as an 
alternative in the treatment of (CADS). 
 
Candida-associated denture stomatitis 
(CADS) 
 
Candida-associated denture stomatitis  is 
affecting about 60% of the subjects carrier of a 
prosthesis.  The major etiologic agent is C. 
albicans  (5,10), although there are findings in 
various studies about other Candida  species 
isolated from material of patients with denture 
stomatitis, such as C. dubliniensis, C. parapsilosis, 
C. krusei, C. tropicalis and C. glabrata (2,5).  
C. albicans is an innocuous commensal of 
the microbial communities of the human oral 
cavity, primarily located on the posterior tongue 
and other oral sites as the mucosa (11,12). 
However,  C. albicans  may become virulent and 
cause candidosis in case of immunodeficiency 
(10). These microorganisms can stick and 
proliferate through the hard and soft tissues of 
the oral cavity, and colonize the inner denture 
surfaces forming a biofilm with different kinds of 
bacteria (5). Thus, dentures act as a reservoir for 
microorganisms,  enabling  Candida  to re-infect 
the mucosal surface continually,  contributing to 
the development of denture stomatitis (3,13).  
CADS was classified according to Newton in 
1962, based exclusively on clinical criteria, into 
three clinical types: type I is characterized by 
localized simple inflammation or pin-point hyper-
aemia. Type II, the most common type, is 
presented as diffuse erythema and oedema of 
palatal mucosal areas covered by dentures. Type 
III is described as granular surface or inflam-
matory papillary hyperplasia in central palate 
(1,14). 
 
Factors  which  affect adhesion and 
biofilm formation of Candida  species on 
acrylic surface 
 
Many factors affect adhesion and biofilm 
formation of Candida on acrylic surfaces, such as 
surface roughness of the inner surface of the 
prosthesis, salivary pellicle, hydrophobic and 
electrostatic interactions (15).   
Surface roughness directly influences initial 
adherence of microorganisms to surfaces, biofilm 
development, and Candida  species colonization. 
The roughest surface of materials provides an 
increased chance of microorganism retention and 
protection from shear forces, wherein micro-
organisms are entrapped within surface irregula-
rities, even during denture cleaning. Polishing of 
dentures provides smooth surface and thus 
reduce the initial adherence and accumulation of 
microorganisms (16). 
The role of human saliva is still contro-
versial regarding Candida adhesion (16). Litera-
ture finding is unclear on whether salivary pellicle 
on acrylic surfaces enhances or decreases initial 
adhesion Candida or even there is no effect at all 
(15).   
The surfaces of acrylic resin are hydro-
phobic. Hydrophobic interaction is an important 
factor that affects adherence of C.  albicans  to 
dentures (15). However, particular  Candida 
species, e.g. C. tropicalis,  C. glabrata and  C. 
dubliniensis, compared with C. albicans, show 
higher adherence, due to their relative surface 
free energy values. Another important factor 
which is related to the development of CADS is 
surface free energy (16). According to C. albicans 
adherence, it has been found that higher surface 
free energy of the resin will influence an increase 
in adherence of C. albicans, while more 
hydrophobic surface is expected to cause less cell 
adherence (16).    
The adherence of Candida to polymers can 
also be influenced by electrostatic interaction 
(17). Yeasts whose surfaces have a positive 
charge are more adherent due to repulsive forces 
between negatively charged yeast cell and 
polymer surfaces (5). 
 
Candida biofilm development  
 
Biofilms are microbial communities enclosed 
in a matrix of extracellular polymeric substances, 
showing different phenotypic features in regard 
to their planktonic or  free-floating counterparts 
(18).  
C. albicans biofilm development progresses 
in three distinct developmental phases: 
Phase I is an early stage and occurs within 
1-11 hours. Candida cells adhere to a substrate 
or surface within two hours, because of non-
specific interactions such as hydrophobic and 
electrostatic forces between the cells and the 
substratum, and the C. albicans cells are blasto-
spores. In addition, glycoproteins are expressed 
to facilitate stronger adhesion. Microcolonies 
appear at 3 to 4 hours, and after 11 hours; 
aggregations of C. albicans appear on substratum 
irregularities.  
Phase II  is intermediate/developmental 
stage and occurs within 12-30 hours. The Candida 
biofilm community can be seen as a bilayer 
composed of yeasts, germ tubes and young 
hyphae with a matrix of extracellular polymeric 
substances (EPS). EPS encapsulation matrix con-
tains polysaccharides produced by  the microbial 
components which are often located in a state of 
reduced metabolic activity, therefore the biofilm 
has a non-cellular layer or EPS covering the 
fungal microcolonies. 
Phase III is the last stage and represents 
the maturation which appears within 38-72 hours. 
Extracellular material enlarges with incubation 
time, while C. albicans yeasts, pseudohyphae and 
hyphae are fully embedded in a matrix (7). 
Biofilm development increase drug resistance 
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substrate adherence (19,20). There is a variety of 
reasons which could explain increased antimicrobial 
resistance of microorganisms in biofilms which are 
surrounded by an extracellular matrix, which makes 
protection from environment and which could slow 
antifungal drug penetration. Phenotypic changes 
which are the result of limited availability of 
nutrients and oxygen in biofilm  containing yeasts 
and a non-growing bacteria cause less susceptibility 
of microbes to antimicrobial drugs (19-22). 
Chandra  et al. have found that antifungal drug 
resistance of amphotericin B, nystatin, fluconazole 
and chlorhexidine increases during biofilm 
development, so that C. albicans cells were highly 
resistant, by 72h in mature biofilms (6). 
 
Therapeutic alternatives among essential 
oils and herbal extracts  
 
Natural products express antibacterial and 
antifungal activities as well as anti-inflammatory 
and antioxidant effects, and it has been proven 
that they are the alternative substitution of 
chemical substances with less adverse effects on 
humans (3,9). A wide variety of the plants 
extracts and essential oils have been traditionally 
used as antifungal agents against C. albicans, 
therefore their role in treatment of Candida-
associated denture stomatitis might be of certain 
importance (3).  
In a biweekly,  double-blind randomized 
clinical trial, patients with complete upper denture 
were medicated with a gel containing essential oil 
of Pelargonium graveolens L.  in order to  treat 
denture stomatitis caused by C. albicans. 
Administration of 1% oil of P. graveolens in the 
form of the gel in the case group was more 
efficient  in reduction of fungal growth  than 
control group. Considering myco-logical culture 
data and clinical examination before and after 
treatment, 34% of patients in the case group 
recovered completely and 56% of them reported 
partial improvement. It has also been reported 
that the gel containing  the essential oil of P. 
graveolens  dramatically reduced erythema in 
patients from case group (23).  
The same authors monitored the effecti-
veness of Satureja hortensis L. essential oil in the 
complete denture wearers, as well. The double-
blind clinical trial included the two-week use of a 
gel containing 1% of S. hortensis  essential oil. 
Participants from the case group had a stati-
stically significant improvement in count of C. 
albicans  colony and the reduction of the 
erythema of palatal mucosa compared with 
control group (87.5% with regard to 30%, 
respectively) (8). The essential oil of S. hortensis 
is reputed to have a wide antimicrobial spectrum, 
including the inhibition of the growth of the 
human bacteria, fungi and yeasts (24,25). The 
main compound in the essential oil of this plant is 
monoterpene carvacrol (26). Carvacrol, oxy-
genated monoterpen, is considered to have 
responsibility for the antifungal effect of the oil 
which seems to be related to the inhibition of 
ergosterol biosynthesis (2). Other natural com-
pounds from essential oils eugenol, farnesol, 
geraniol, linalool, menthol, menthone, terpinen-
4-ol,  α-terpineol and tyrosol, along with carva-
crol, expressed strong antifungal in vitro activity, 
as well. The investigation implied oral Candida 
isolates from denture wearers whereby minimal 
inhibitory concentrations of compounds ranged 
from 0.03% to 8%. (2). Linalool, terpinen-4-ol, 
geraniol and eugenol were the most effective 
against  C. albicans  while carvacrol was active 
aginst C. glabrata and C. tropicalis, as well (2). 
Carvacrol manifested a powerful activity against 
Candida  spp. even against fluconazole-resistant 
isolates (28,29). Besides carvacrol, in vitro anti-
Candida  activities at low concentrations were 
exhibited by geraniol, linalool, menthol, terpinen-
4–ol,  α-terpineol and eugenol against fluco-
nazole-resistant C. krusei and C. glabrata (27).  
Zataria multiflora Boiss. has shown the 
beneficial effect to the treatment of CADS. The 
open,  randomized, controlled, clinical study 
assessed the difference in efficiency of 2% gel 
containing miconazole and 0.1% gel containing 
essential oil of Z. multiflora which were admini-
stered four times daily for 2 weeks. Both 
preparations were able to significantly reduce the 
erythema surface and decrease the colony count 
of the palatal mucosa. Miconazole was more 
potent in reducing the number of denture 
colonies, but essential oil of Z. multiflora 
alleviated  the erythema of the palate more 
efficiently than miconazole gel. It is considered 
that the main components, thymol, carvacrol, p-
cymene, linalool and γ-terpinen were responsible 
for such activities of the oil (30). 
Natural products which are known on the 
basis of their folklore usage could be the effective 
agents for the treatment of denture stomatitis. 
Garlic has a number of physiological effects with 
lack of side effects, so it could be a suitable 
substitution for nystatin in healing of oral 
candidosis, particularly related to denture stoma-
titis. In a randomized, double-blind clinical trial, 
Bakhshi et al. compared garlic aqueous solution 
with nystatin mouthwash in the patients with 
denture candidosis. After four weeks of oral 
application of nystatin suspension or garlic 
aqueous solution, three times a day, researchers 
noticed that the changes in the length and width 
of erythema were significantly ameliorated in 
both treatment groups. A more rapid recovery 
was demonstrated in participants who used 
nystatin, but both groups resulted in significant 
recovery (31).  
Pinelli et al. investigated the treatment of 
denture stomatitis in institution and compared its 
activity with nystatin and miconazole. Patients 
used miconazole oral gel, nystatin drops or R. 
communis  oil, for 30 days of treatment. It was 
interesting that neither group showed a stati-
stically significant suppression in the numbers of 
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and  R. communis  oil were able to improve the 
clinical presentation of stomatitis in patients, with 
statistical significance (32). A weak effect of 
nystatin might be attributed to resistance of C. 
albicans,  which has been constantly increasing, 
and the low adherence of elderly to the treatment 
(33). Mordenti et al. claimed that sodium ricino-
leate from castor oil polymer may change the 
formation of biofilm by decreasing its acidity 
(34). Another possible mechanism against fungi 
may be the influence to the chitin, a long-chain 
polymer of N-acetylglucosamine, the main com-
ponent of the cell walls of C. albicans (35). 
Punica granatum  L. fruit extract could be 
effective topical antifungal agent for the treat-
ment of Candida  associated denture stomatitis. 
In a clinical trial, patients used 2% miconazole or 
1.25%  P. granatum  extracts gels three times a 
day topically, for two weeks. All patients from the 
study reported the improvement of symptoms or 
total recovery of lesions. The outcome of the 
study was that applied gels achieved regular and 
satisfactory clinical response as well as the 
laboratorial negativity of yeasts. Tannins and 
polyphenols are the major compounds of the 
extract of the fruits of P. granatum  and consi-
dered to be responsible for the effect. Tannins 
may affect the cell membrane of the yeasts due 
to precipitation of proteins, however, the specific 
mechanism of action against Candida is not well 
studied (36). 
In addition to in vivo  studies, there is a 
number of in vitro studies examining the inhibi-
tion of adhesion of the C. albicans  cells to the 
surface of acrylates by the natural antifungal 
agents. 
Sookto  et al.  found that essential oil of 
Salvia officinalis  L. manifested strong anti-
candidal activity and expressed inhibitory effects 
on the adhesion of the C. albicans to polymethyl 
methacrylate resin surface.  It was established 
that  immersion of acrylate in the essential oil at  
concentrations of 2.780 g/l, 1.390 g/l and 0.695 
g/l, at room temperature for 30 min, significantly 
decreased the adhesion of C. albicans strains to 
polymethyl methacrylate resin surface, compared 
to distilled water (37). The major compounds 
which are considered to be responsible for 
antimicrobial activity are oxygenated hydrocarbons, 
monoterpene and sesquinterpene hydrocarbons 
particularly 1,8-cineole, α-β-thujone and borneol 
(38). 
A leaf ethanolic extract of Streblus asper 
Lour. manifested strong activity in suppressing C. 
albicans adhesion to acrylic in the in vitro study. 
The minimum concentration of the extract able to 
significantly reduce the Candida-adherence after 
a 4h exposure was 31.25 mg/ml. The concen-
tration of 62.5 mg/ml of the extract caused a 
significant reduction of Candida  adhesion to 
acrylic and occurred after 1 min of exposure. 
Researchers also conducted a pre-treatment of 
yeast with 62.5 mg/ml of the extract for 1h, 
before adhesion test, and reported significant 
suppressing of the adherence, 20.54%, compared 
to the untreated control (39). S. asper can inhibit 
the germination of C. albicans, thus the extract, 
probably, interferes in changes of cell surface 
hydrophobicity, and consequently reduces Candida 
adhesion (40). 
A pretreatment of acrylic surface with 
ethanolic extract of Boesenbergia pandurata 
(Roxb.)  Schltr.  rhizome resulted in significantly 
reduced adhesion of C. albicans to denture acrylic 
surface. The pretreatment implied immersing of 
acrylic in solution of the extract at concentrations 
of 25, 50 and 100 mg/ml and then inoculation 
with  C. albicans. The greatest inhibition of 
adherent yeasts cells was recorded at 100 mg/ml 
and was approximately 75% (41). The effects of 
B. pandurata extract are visible mostly due to 
changes in cell surface of the yeasts, interacting 
with the production of extracellular matrix or a 
fibrillar floccular layer and modulating of the 
surface hydrophobicity. It is also possible that B. 
pandurata  extract decreases the adhesion of 
yeasts to acrylic surfaces by blocking adhesins on 
the surface of the cell (42).  
An ethanolic extract of fruits from Phyllan-
thus emblica  L. was also investigated by the 
same Thailand investigators. In the study they 
monitored the efficacy of the extract to prevent 
the attachment of C. albicans to denture acrylic 
surfaces. The inhibition of adhesion was achieved 
at concentrations of 75-300 mg/ml of the extract 
reducing 36%-80% of the yeasts cells (43). 
Geraniin, quercetin 3-β-D-glucopyranoside, kaemp-
ferol 3-β-D-glucopyranoside, isocorilagin, quercetin 
and kaempferol present in P. emblica may affect 
the cell surface structures or integrity and could 
mask the adhesions  on the yeast or on the 
receptors (44). 
A polymethyl methacrylate based tissue 
conditioner incorporated with origanum oil exhibited 
a strong resistance to the Candida-adhesion 
without influence on the physical properties of the 
material. Sixty vol% origanum oil in tissue 
conditioner significantly reduced the number  of 
yeast cells, 16±1.15 cells/mm
2  at
  1 day  and 
32±4.00  cells/mm
2  at 1 week, in comparison to 
control, 90±6.80 cells/mm
2  at 1 day and 165 
±7.63 cells/mm
2 at 1 week. The oil’s antimicrobial 
effect was found to be based on the inhibition of 
germination and filament formation of a microbe, 
thanks to carvacrol and thymol (45).  
Baicalein is a flavonoid, a major component 
of  Scutellaria baicalensis Georgi, which was 
examined for its preventive anti  Candida-
adhesive and antifungal properties. Confocal laser 
scanning microscopy  indicated that over 70% 
inhibition of C. albicans  biofilms was achieved 
with dimethyl sulfoxide solution of baicalein at 
concentrations ranged from 4 µg/ml to 32 µg/ml. 
The water–hydrocarbon two-phase test showed a 
decrease in hydrophobicity of yeasts cell surface 
when treated with baicalein, which was the result 
of inhibition of biofilm forming (46).  
The hydrophobicity of C. albicans  cell 
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A. Juss. aqueous extract made of leaves, as well. 
The concentration of 0.01 g/ml of A. indica 
extract managed to increase the hydrophobicity 
and consequently reduce the capacity of cells to 
adhere to composit resin. On the other hand, the 
extract was unable to inhibit the growth of C. 
albicans cells, probably due to low concentration 
of bioactive compounds extracted with water, 
which may be increased with an alcohol as 
extracting agent (47).  
An  in vitro  study examined the effects of 
well-known antifugal natural product Melaleuca 
alternifolia (Maiden & Betche) Cheel essential oil 
on the inhibition of C. albicans when mixed with 
tissue conditioners. The mixture of Coe-Comfort 
or Fitt conditioners with 1 ml of 20% M. alternifolia 
oil demonstrated a strong and rapid inhibitory and 
fungicidal activity of C. albicans. In in vivo study, 
patients with Coe-Comfort dentures with 1 ml of 
incorporated essential oil reported a significant 
decrease in palatal inflammation which was almost 
the same as in patients receiving nystatin. A high 
significant  inhibition in C. albicans  growth was 
found in group with denture containing essential 
oil, compared to nystatin and control group (48). 
 
 
Conclusion  
 
Having in mind that denture stomatitis is a 
common disease in total denture wearer, and 
that it is most commonly of fungal etiology, 
application of non-synthetic, completely natural 
substances, such as essential oils and extracts, 
may be suggested as promising alternative for 
treatment of CADS. However, further works and 
clinical studies are recommended before their 
usage. It is important to use standardized, 
scientifically studied plant medications due to the 
fact that not all herbs are safe and nontoxic. 
Considering the increasing resistance of 
the fungi against antifungal agents, formation of 
Candida biofilm, and generally positive attitude of 
patients for herbal treatment, natural products 
could be the alternative substitutions of chemical 
substances with less adverse effects on humans, 
which is relevant for effective treatment of 
Candida infections.  
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PRIRODNA JEDINJENJA U TERAPIJI PROTEZNOG STOMATITISA 
IZAZVANOG GLJIVAMA RODA CANDIDA 
 
Milica Petrović, Milica Kostić, Milena Kostić, Nebojša Krunić, Marko Igić, Zoran Pešić, 
Suzana Otašević 
 
 
Protezni stomatitis je veoma čest inflamatorni proces kod nosilaca mobilnih zubnih 
proteza,  multifaktorijalne  etiologije.  Najčešće  se  dovodi  u  vezu  sa  gljivama  roda 
Candida, pri čemu je Candida albicans glavni uzročnik. Tretman proteznog stomatitisa 
izazvanog  kandidom  je  težak  i  kompleksan  zbog  multifaktorijalne  etiologije,  čestih 
recidiva  i  rezistencije  mikroorganizama  na  antifungalne  lekove.  Cilj  ovog  rada  bio  je 
istaći najbitnije faktore koji utiču na adherenciju gljivama roda Candida za akrilat i da 
razmotri  upotrebu  lekovitog  bilja  kao  alternative  u  terapiji  proteznog  stomatitisa 
izazvanog Candida spp. Mnogi faktori utiču na adheziju  i formiranje biofilma Candida 
spp.  na  površini  akrilata,  kao  što  su  hrapavost  površine  unutrašnje  strane  proteze, 
salivarna pelikula, hidrofobnost i elektrostatske interakcije. Imajući u vidu činjenicu da 
je protezni stomatitis često oboljenje kod onih koji nose totalne zubne proteze, da je 
najčešće  gljivične  etiologije,  da  razvoj  biofilma  povećava  rezistentnost  na  lekove, 
primena nesintetičkih sredstava, potpuno prirodnih, kao što su etarska ulja i ekstrakti, 
mogu biti dobra alternativa u tretmanu proteznog stomatitisa izazvanog kandidom. Acta 
Medica Medianae 2014;53(1):73-79. 
 
Ključne reči: protezni stomatitis, Candida albicans, esencijalna ulja, biljni ekstrakti 
 